Janux Therapeutics Inc (JANX)
Janux - Investor Relations - Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Janux - Investor Relations - Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
PDF Solutions® Reports Second Quarter 2026 Financial Results
BLINK CHARGING ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
WillScot Declares Quarterly Cash Dividend
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Arrow Electronics Reports Strong Second-Quarter 2026 Results
Consensus Cloud Solutions, Inc. Reports Second Quarter 2026 Results; Reaffirms Full Year 2026 and Releases Q3 2026 Guidance; Increases Stock Buyback Program to $200 Million
10x Genomics Reports Second Quarter 2026 Financial Results
SIGA - SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
Halozyme - HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
STAG INDUSTRIAL RECEIVES BBB INVESTMENT GRADE RATING FROM S&P GLOBAL RATINGS
Ross Stores, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE